Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)
NCT02244320 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4150
Last updated 2014-09-19
Summary
The objective of the observational study were to investigate the switch from phytotherapy to ALNA® after at least 4 weeks of phytotherapy and still presented with a symptom sum score of ≥ 8 points (International Prostate Symptom Score (IPSS))
Conditions
- Prostatic Hyperplasia
Interventions
- DRUG
-
Tamsulosin
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-09-30
- Primary Completion
- 2003-05-31
More Related Trials
-
Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients
NCT02244229 ·Status: COMPLETED ·Phase: PHASE4
-
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment
NCT00090103 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
NCT01673490 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia
NCT02244242 ·Status: COMPLETED ·Phase: PHASE4
-
A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH
NCT00510406 ·Status: COMPLETED ·Phase: PHASE2
-
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.
NCT02417844 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score
NCT00540891 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)
NCT02245542 ·Status: COMPLETED
-
Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients
NCT01736033 ·Status: UNKNOWN ·Phase: PHASE4
-
Benign Prostatic Hyperplasia in Taiwan
NCT00941343 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms
NCT02715024 ·Status: COMPLETED ·Phase: PHASE4
-
Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
NCT00701779 ·Status: COMPLETED ·Phase: PHASE4
-
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
NCT00224120 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia
NCT00399464 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms
NCT02245490 ·Status: COMPLETED ·Phase: PHASE4
-
A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockers for Benign Prostatic Hyperplasia
NCT07144709 ·Status: COMPLETED
-
Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients with Prostate Volumes ≤ 40 Ml: a Prospective Comparative Study
NCT06809205 ·Status: COMPLETED ·Phase: PHASE4
-
Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia
NCT05531344 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.
NCT02417831 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic Prostatitis
NCT00913315 ·Status: UNKNOWN ·Phase: NA
-
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
NCT01726270 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia
NCT00409357 ·Status: COMPLETED ·Phase: PHASE2
-
Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia
NCT02313233 ·Status: COMPLETED ·Phase: NA
-
Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms
NCT01021332 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia
NCT00284518 ·Status: COMPLETED ·Phase: PHASE2